(12) United States Patent (10) Patent No.: US 7,662,389 B2 Clark Et Al

Total Page:16

File Type:pdf, Size:1020Kb

(12) United States Patent (10) Patent No.: US 7,662,389 B2 Clark Et Al USOO7662389B2 (12) United States Patent (10) Patent No.: US 7,662,389 B2 Clark et al. (45) Date of Patent: Feb. 16, 2010 (54) USE OF SERUM AMYLOIDA GENE IN Cotton et al., Proc. Natl. Acad. Sci. USA 85.4397 (1988): “Reactivity DAGNOSIS AND TREATMENT OF of cytosine and thymine in single-base-pair mismatches with GLAUCOMIA AND IDENTIFICATION OF hydroxylamine and osmium tetroxide and its application to the study ANT-GLAUCOMAAGENTS of mutations'. Cotton, Mutat. Res. 285:125-144 (1993); "Current methods of muta tion detection'. (75) Inventors: Abbot F. Clark, Arlington, TX (US); Croninet al., Human Mutation 7:244-255 (1996); "Cystic Fibrosis Wan-Heng Wang, Grapevine, TX (US); Mutation Detection by Hybridization to Light-Generated DNA Loretta Graves McNatt, Hurst, TX Probe Arrays”. (US) Ermilov et al. (1993); Arkh Patol.; “Senile amyloidosis of the eye as a manifestation of senile cerebral amyloidosis' abstract with article (73) Assignee: Alcon, Inc., Hunenberg (CH) in Russian 55(6):43-45. Furlenato, CJ, and Campa A, Biochem. Biophys. Res. Commun 268:405-408 (2002), “A novel function of serum amyloid A. apotent (*) Notice: Subject to any disclaimer, the term of this stimulus for the release of tumor necrosis factor-alpha, interleukin-1 patent is extended or adjusted under 35 beta, and interleukin-8 by human blood neutrophil”. U.S.C. 154(b) by 130 days. Gasparini et al., Mol. Cell Probes 6:1-7 (1992); "Restriction site generating-polymerase chain reaction (RG-PCR) for the probeless (21) Appl. No.: 11/615.454 detection of hidden genetic variation: application to the study of some common cystic fibrosis mutations'. (22) Filed: Dec. 22, 2006 Gibbs et al., Nucleic Acids Res. 17:2437-2448 (1989); "Detection of single DNA base differences by competitive oligonucleotide prim (65) Prior Publication Data ing. Griffin et al., Appl. Biochem Biotechnol. 38: 147-159 (1993); “DNA US 2007/0208043 A1 Sep. 6, 2007 Sequencing Recent Innovations and Future Trends'. Guatelli, J. C., et al., Proc. Natl. Acad. Sci. USA 87: 1874-1878 Related U.S. Application Data (1990); “Isothermal, in vitro amplification of nucleic acids by a multienzyme reaction modeled after retroviral replication'. (63) Continuation-in-part of application No. 11/000,757, HagiharaKetal, 2004, Biochemical and Biophysical Research Com filed on Dec. 1, 2004, now Pat. No. 7,357,931. munications, “IL-6 plays a critical role in the synergistic induction of human serum Amyloid A (SAA) gene when stimulated with proinflammatory cytokines as analysed with an SAA isoform real (51) Int. Cl. time quantitative RT-PCR assay system”, 314, 363-369. A6 IK 39/00 (2006.01) Hayashi, Genet. Anal. Tech. Appl. 9:73-79 (1992); "PCR-SSCP: A (52) U.S. Cl. ........................................ 424/184.1: 514/2 Method for Detection of Mutations'. (58) Field of Classification Search ........... ... None He, R. Sang H. Ye, RD, Serum Amyloid A induces IL-8 secretion See application file for complete search history. through a G protein-coupled receptor, FPRL1/LXA4R. Blood 101: 1572-1581 (2003). (56) References Cited Hsu et al., Carcinogenesis 15:1657-1662(1994): “Detection of DNA point mutations with DNA mismatch repair enzymes'. U.S. PATENT DOCUMENTS Krasnov et al. (Jan.-Mar. 1996); Vestn Oftalmol. “Morphological features of senile and secondary amyloidosis of the iris and Sclera in 4,656,127 A 4, 1987 Mundy patients with glaucoma' abstract with article will be in Russian 4,998,617 A 3/1991 Ladd, Jr. et al. 12(1):24-6. 5,459,039 A 10, 1995 Modrich et al. Kumon, Y. et al. Acute-phase, but not constitutive serum amyloid A 5,545,628 A 8, 1996 Deboecket al. (SAA) is chemotactic for cultured human aortic Smooth muscle cells, 5,593,826 A 1/1997 Fung et al. AMYLOID 9:237-241 (2002a). 6,433,018 B1 8/2002 Siddiquiet al. Kumon Y. et al., Transcriptional regulation of Serum Amyloid Al 7,357,931 B2 4/2008 Clark et al. gene expression in human aortic Smooth muscle cells involves 2002/0102581 A1 8/2002 Hageman et al. CCAAT/enhancer binding proteins (C/EBP) and is distinct from 2003/0078274 A1* HepG2 cells, Scand. J. Immunol. 56:504-511 (2002b). 4/2003 Lipton ........................ 514,256 Kumon, Y. et al., Dexamethasone, but not IL-1 alone, upregulates acute-phase serum amyloid A gene expression and production by FOREIGN PATENT DOCUMENTS cultured human aortic smooth muscle cells, Scand J. Immunol. 53.7- 12 (2001). EP 1196 167 B 4/2006 FR 2650840 8, 1989 (Continued) WO WO91/02087 A1 2, 1991 WO WO92, 15712 A1 9, 1992 Primary Examiner Anand U Desai WO WO94/16101 A2 T 1994 (74) Attorney, Agent, or Firm Teresa J. Schultz WO WO94/16101 A3 T 1994 (57) ABSTRACT WO WO 2005/060542 A2 7/2005 WO WO 2005/060542 A3 7/2005 The present invention provides compositions and methods for treating glaucoma, methods for diagnosing glaucoma, and OTHER PUBLICATIONS methods for identifying agents which may be useful in the treatment of glaucoma. More specifically, the present inven Barany, Proc. Natl. Acad. Sci. USA 88:189-193 (1991); “Genetic disease detection and DNA amplification using cloned thermostable tion describes the use of agents that modulate the expression ligase'. of serum amyloid A. Bengtsson, “Incidence of manifest glaucoma.” BrJOphthalmol, vol. 73, pp. 483-487 (1989). 2 Claims, 14 Drawing Sheets US 7,662,389 B2 Page 2 OTHER PUBLICATIONS Saiki et al., Proc. Natl. Acad. Sci. USA 86:6230-6234 (1989); "Genetic analysis of amplified DNA with immobilized sequence Kuppuswamy, M. N. et al. Proc. Natl. Acad. Sci. (U.S.A.) 88: 1143 specific oligonucleotide probes'. 1147 (1991); "Single nucleotide primer extension to detect genetic Sanger et al. Proc. Natl. Acad. Sci. USA 74:5463 (1977); “DNA diseases: Experimental application to hemophilia B (factor IX) and sequencing with chain-terminating inhibitors'. cystic fibrosis genes'. Kwoh, D.Y., et al., Proc. Natl. Acad. Sci. USA 86: 1173-1177 (1989); Schwartzetal. (1982); Ophthalmology, 89(4):394-401 Sokolov, B.P. “Transcription-based amplification system and detection of ampli Nucl. Acids Res. 18:3671 (1990); “Primer extension technique for fied human immunodeficiency virus type 1 with a bead-based sand the detection of single nucleotide in genomic DNA”. wich hybridization format”. Sokolov, B.P. Nucl. Acids Res. 18:3671 (1990); “Primer extension Landegren, U. et al., Science 241: 1077:1080 (1988); "A Ligase technique for the detection of single nucleotide in genomic DNA'. Mediated Gene Detection Technique'. Strong, N. P. “How optometrists screen for glaucoma: A Survey', Liang, J.S., Sloane, J.A., Wells, J.M., Abraham, C.R., Fine, R.E., and Ophthal. Physiol. Opt., 12:3-7 (1992). Sipe, J.D., Evidence for local production of acute phase response Syvanen, A. -C., et al., Genomics 8:684-692 (1990); "A Primer apolipoprotein serum amyloid A in Alzheimer's disease brain, Guided Nucleotide Incorporation Assay in the Genotyping of Neurosci. Lett. 225:73-76 (1997). Apollipoprotein E'. Lizardi, P. M. et al., Bio/Technology 6: 1197-1202 (1988): “Expo Thorn, C.F. and Whitehead, A.S. Differential glucocorticoid nential Amplification of Recombinant-RNA Hybridization Probes”. enhancement of the cytokine-driven transcriptional activation of the Maxam and Gilbert, Proc. Natl. Acad. Sci. USA 74:560 (1977); "A human actue phase serum amyloid A genes, SAA1 and SAA. J. new method for sequencing DNA”. Immunol. 169:399-406 (2002). Miida T., Yamada, T., Yamadera, T., Ozaki, K., Inano, K., Okada, M., Tobe et al., Nucleic Acids Res. 24:3728-3732 (1996); "Single-well Serum amyloid A protein generates pre-beta 1 high-density genotyping of diallelic sequence variations by a two-color ELISA lipoprotein from alpha-migrating high-density lipoprotein, Biochem. based oligonucleotide ligation assay'. 38(51): 16958-16962 (1999). Uhlar C et al., 1997. “Use of the acute phase serum anyloid A2 Myers et al., Nature 313:495 (1985a); "Detection of singie base (SAA2) gene promoter in the analysis of pro-and anti-inflammatory Substitutions in total genomic DNA”. mediators: differential kinetics of SAA2 promoter induction by IL-1 Myers et al., Science 230:1242 (1985b); "Detection of Single Base beta and TNF-alpha compared to IL06”, Journal of Immunological Substitutions by Ribonuclease Cleavage at Mismatches in Methods, 203, 123-130, especially Abstract. RNA:DNA Duplexes”. Uhlar, C.M., and Whitehead, A.S. Serum amyloid A, the major Nickerson, D. A. et al., Proc. Natl. Acad. Sci. USA 87:8923-27 vertebrate acute-phase reactant, Eur, J. Biochem. 265:501-523 (1990); "Automated DNA diagnostics using an ELISA-based (1999). oligonucleotide ligation assay. Urleli-Shoval, S., Cohen, P. Eisenberg, S., and Matzner, Y. Wide O'Hara, R., Murphy, E.P. Whitehead, A.S., FitzGerald, O., and spread expression of serum amyloid A in histologically normal Bresnihan, B., Acute-phase serum amyloidA production by rheuma human tissue. Predominant localization to the epithelium, J. toid arthritis synovial tissue, Arthritis Res. 2: 142-148 (2000). Histochem. Cytochem. 46:1377-1384 (1998). Orita et al., Proc. Natl. Acad. Sci. USA86:2766 (1989); "Detection of polymorphisms of human DNA by gel electrophoresis as single van der Luijt et al., Genomics 20:1-4 (1994); "Rapid Detection of Strand conformation polymorphisms’. Translation-Terminating Mutations at the Adenomatous Polyposis PCT International Search Report of a related PCT Application No. Coli (APC) Gene by Direct Protein Truncation Test”. PCT/US04/4.0156, mailed Jul 26, 2006. Vaughan, D. et al., In: General Ophthalmology, Appleton & Lange, Prosser, Tibtech 11:238 (1993): “Detecting single-base mutations”. Norwalk, Conn., pp. 213-230 (1992). Roest et al., Hum. Mol. Genet. 2:1717-1721 (1993); “Protein trun Written Opinion of the International Searching Authority of a related cation test (PTT) for rapid detection of translation-terminating muta PCT Application No.
Recommended publications
  • Influence of Serum Amyloid a (SAA1) And
    Influence of Serum Amyloid A (SAA1) and SAA2 Gene Polymorphisms on Renal Amyloidosis, and on SAA/ C-Reactive Protein Values in Patients with Familial Mediterranean Fever in the Turkish Population AYSIN BAKKALOGLU, ALI DUZOVA, SEZA OZEN, BANU BALCI, NESRIN BESBAS, REZAN TOPALOGLU, FATIH OZALTIN, and ENGIN YILMAZ ABSTRACT. Objective. To evaluate the effect of serum amyloid A (SAA) 1 and SAA2 gene polymorphisms on SAA levels and renal amyloidosis in Turkish patients with familial Mediterranean fever (FMF). Methods. SAA1 and SAA2 gene polymorphisms and SAA levels were determined in 74 patients with FMF (39 female, 35 male; median age 11.5 yrs, range 1.0–23.0). All patients were on colchicine therapy. SAA1 and SAA2 gene polymorphisms were analyzed using polymerase chain reaction restriction fragment length polymorphism (PCR-RFLP). SAA and C-reactive protein (CRP) values were measured and SAA/CRP values were calculated. Results. The median SAA level was 75 ng/ml (range 10.2–1500). SAA1 gene polymorphisms were: α/α genotype in 23 patients (31.1%), α/ß genotype in 30 patients (40.5%), α/γ genotype in one patient (1.4 %), ß/ß genotype in 14 patients (18.9%), ß/γ genotype in 5 patients (6.8 %), and γ/γ geno- type in one patient (1.4%). Of the 23 patients who had α/α genotype for the SAA1 polymorphism, 7 patients had developed renal amyloidosis (30.4%) compared to only one patient without this geno- type (1/51; 2.0%); p < 0.001. SAA2 had no effect on renal amyloidosis. SAA1 and SAA2 genotypes had no significant effect on SAA levels.
    [Show full text]
  • Gene Expression Atlas.Pptx
    ArrayExpress Gene Expression Atlas Investigating gene expression patterns The Bioinformatics Roadshow – Rotterdam Erasmus Postgraduate school Molecular Medicine Ibrahim Emam Functional Genomics Group European Bioinformatics Institute ArrayExpress – two databases May 2, 2012 2 How we view experiments… • Given one experiment where the effect of a particular compound treatment is assayed from two different strains in four different tissue types. 02/05/2012 3 Examine profile of Saa4 in one experiment • With respect to Compound Treatment 02/05/2012 4 Examine profile of Saa4 in one experiment • With respect to Genotype 02/05/2012 5 Examine profile of Saa4 in one experiment • With respect to Organism Part (Tissue) 02/05/2012 6 Atlas construction Atlas construction - example Meta-analysis framework • For each experiment: • Identify differentially expressed genes between groups of samples • A gene is significantly differentially expressed if the combined F- statistic derived from all pairwise comparisons of the means of a gene's expression levels across factors has a sufficiently small adjusted p-value. • Score every condition/gene/experiment triplet – this score gives us the likelihood that this gene is differentially expressed for this condition in the given experiment • Correct these scores for multiple testing and make a cut-off – differentially expressed: yes/no • Repeat for all experiments 02/05/20129 Meta-analysis framework-cont’d • For every condition-gene pair count in how many experiments it is differentially expressed • The result is
    [Show full text]
  • Diversity and Complexity of the Mouse Saa1 and Saa2 Genes
    Exp. Anim. 63(1), 99–106, 2014 —Original— Diversity and Complexity of the Mouse Saa1 and Saa2 genes Masayuki MORI1), Geng TIAN1), Akira ISHIKAWA2), and Keiichi HIGUCHI1) 1)Department of Aging Biology, Institute of Pathogenesis and Disease Prevention, Shinshu University Graduate School of Medicine, 3–1–1 Asahi, Matsumoto, Nagano 390-8621, Japan 2)Laboratory of Animal Genetics, Division of Applied Genetics and Physiology, Graduate School of Bioagricultural Sciences, Nagoya University, Chikusa, Nagoya, Aichi 464-8601, Japan Abstract: Mouse strains show polymorphisms in the amino acid sequences of serum amyloid A 1 (SAA1) and serum amyloid A 2 (SAA2). Major laboratory mouse strains are classified based on the sequence as carrying the A haplotype (e.g., BALB/c) or B haplotype (e.g., SJL/J) of the Saa1 and Saa2 gene unit. We attempted to elucidate the diversity of the mouse Saa1 and Saa2 family genes at the nucleotide sequence level by a systematic survey of 6 inbred mouse strains from 4 Mus subspecies, including Mus musculus domesticus, Mus musculus musculus, Mus musculus castaneus, and Mus spretus. Saa1 and Saa2 genes were obtained from the mouse genome by PCR amplification, and each full-length nucleotide sequence was determined. We found that Mus musculus castaneus mice uniquely possess 2 divergent Saa1 genes linked on chromosome 7. Overall, the mouse strains had distinct composite patterns of amino acid substitutions at 9 positions in SAA1 and SAA2 isoforms. The mouse strains also had distinct composite patterns of 2 polymorphic upstream regulatory elements that influenced gene transcription in in vitro reporter assays. B haplotype mice were revealed to possess an LTR insertion in the downstream region of Saa1.
    [Show full text]
  • Transposable Elements As Sensors of SARS-Cov-2 Infection
    bioRxiv preprint doi: https://doi.org/10.1101/2021.02.25.432821; this version posted February 25, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. Transposable elements as sensors of SARS-CoV-2 infection Matan Sorek1,2,*, Eran Meshorer1,2,* and Sharon Schlesinger3,* 1Department of Genetics, The Institute of Life Sciences, The Hebrew University of Jerusalem, Edmond J. Safra Campus, Jerusalem 9190100, Israel, 2Edmond and Lily Safra Center for Brain Sciences (ELSC), The Hebrew University of Jerusalem, Edmond J. Safra Campus, Jerusalem 9190100, Israel 3Department of Animal Sciences, Faculty of Agriculture, The Hebrew University of Jerusalem, Rehovot 7610001, Israel *Corresponding authors ([email protected]; [email protected]; [email protected]) 1 bioRxiv preprint doi: https://doi.org/10.1101/2021.02.25.432821; this version posted February 25, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. Abstract Transposable elements (TEs) are induced in response to viral infections. TEs induction triggers a robust and durable interferon (IFN) response, providing a host defense mechanism. Still, the connection between SARS-CoV-2 IFN response and TEs remained unexplored. Here, we analyzed TE expression changes in response to SARS-CoV-2 infection in different human cellular models.
    [Show full text]
  • Human Serum Amyloid a (SAA)
    Clinical and Inflammation Research Area Human serum amyloid A (SAA) erum amyloid A recombinant SAA as well as purified endogenous apolipoprotein SAA has a tendency to aggregate and form oligomers Sfamily consists of (4-6). Presumably, the association of SAA molecules three members that in is mediated by amino acid residues located within human beings are cod- α-helix regions 1 (residues 2-8) and 3 (residues ed by different genes: 52-59) (4). SAA1, SAA2, and SAA4 (reviewed in 1-3). SAA1 The biological function of SAA and SAA2 are so-called acute phase isoforms. The biological function of SAA in inflammation is Their expression is in- unclear. It has been suggested that SAA is involved creased in response to in the recycling of cholesterol from damaged tissues. inflammation. SAA4 is It might play the role of a signaling molecule that a constitutive isoform, redirects HDL particles to activated macrophages the expression of which does not change during an and mediates the removal of stored cholesterol from acute-phase response. In addition, one more related them. Released cholesterol is then transferred to HDL gene (SAA3) has been identified, although this gene to be used again in the membranes of new cells that are is not expressed in human beings. required during acute inflammation and tissue repair (7). Besides that, published studies demonstrate Biochemical properties of SAA that recombinant SAA exhibits significant proinflammatory activity by inducing the synthesis SAA1 and SAA2 are synthesized in the liver of several cytokines and promoting chemotaxis for and secreted to the blood. When in the blood, monocytes and neutrophils in vitro (1, 8).
    [Show full text]
  • (SAA2) (NM 030754) Human Recombinant Protein Product Data
    OriGene Technologies, Inc. 9620 Medical Center Drive, Ste 200 Rockville, MD 20850, US Phone: +1-888-267-4436 [email protected] EU: [email protected] CN: [email protected] Product datasheet for TP304977 serum amyloid A2 (SAA2) (NM_030754) Human Recombinant Protein Product data: Product Type: Recombinant Proteins Description: Recombinant protein of human serum amyloid A2 (SAA2), transcript variant 1 Species: Human Expression Host: HEK293T Tag: C-Myc/DDK Predicted MW: 13.3 kDa Concentration: >50 ug/mL as determined by microplate BCA method Purity: > 80% as determined by SDS-PAGE and Coomassie blue staining Buffer: 25 mM Tris.HCl, pH 7.3, 100 mM glycine, 10% glycerol Bioactivity: Cell treatment (PMID: 29757436) Preparation: Recombinant protein was captured through anti-DDK affinity column followed by conventional chromatography steps. Storage: Store at -80°C. Stability: Stable for 12 months from the date of receipt of the product under proper storage and handling conditions. Avoid repeated freeze-thaw cycles. RefSeq: NP_110381 Locus ID: 6289 UniProt ID: P0DJI9 RefSeq Size: 594 Cytogenetics: 11p15.1 RefSeq ORF: 366 Synonyms: SAA; SAA1 This product is to be used for laboratory only. Not for diagnostic or therapeutic use. View online » ©2021 OriGene Technologies, Inc., 9620 Medical Center Drive, Ste 200, Rockville, MD 20850, US 1 / 2 serum amyloid A2 (SAA2) (NM_030754) Human Recombinant Protein – TP304977 Summary: This gene encodes a member of the serum amyloid A family of apolipoproteins. The encoded preproprotein is proteolytically processed to generate the mature protein. This protein is a major acute phase protein that is highly expressed in response to inflammation and tissue injury.
    [Show full text]
  • Influence of Serum Amyloid a (SAA1) and SAA2 Gene Polymorphisms On
    Influence of Serum Amyloid A (SAA1) and SAA2 Gene Polymorphisms on Renal Amyloidosis, and on SAA/ C-Reactive Protein Values in Patients with Familial Mediterranean Fever in the Turkish Population AYSIN BAKKALOGLU, ALI DUZOVA, SEZA OZEN, BANU BALCI, NESRIN BESBAS, REZAN TOPALOGLU, FATIH OZALTIN, and ENGIN YILMAZ ABSTRACT. Objective. To evaluate the effect of serum amyloid A (SAA) 1 and SAA2 gene polymorphisms on SAA levels and renal amyloidosis in Turkish patients with familial Mediterranean fever (FMF). Methods. SAA1 and SAA2 gene polymorphisms and SAA levels were determined in 74 patients with FMF (39 female, 35 male; median age 11.5 yrs, range 1.0–23.0). All patients were on colchicine therapy. SAA1 and SAA2 gene polymorphisms were analyzed using polymerase chain reaction restriction fragment length polymorphism (PCR-RFLP). SAA and C-reactive protein (CRP) values were measured and SAA/CRP values were calculated. Results. The median SAA level was 75 ng/ml (range 10.2–1500). SAA1 gene polymorphisms were: α/α genotype in 23 patients (31.1%), α/ß genotype in 30 patients (40.5%), α/γ genotype in one patient (1.4 %), ß/ß genotype in 14 patients (18.9%), ß/γ genotype in 5 patients (6.8 %), and γ/γ geno- type in one patient (1.4%). Of the 23 patients who had α/α genotype for the SAA1 polymorphism, 7 patients had developed renal amyloidosis (30.4%) compared to only one patient without this geno- type (1/51; 2.0%); p < 0.001. SAA2 had no effect on renal amyloidosis. SAA1 and SAA2 genotypes had no significant effect on SAA levels.
    [Show full text]
  • Comparison of Gene Expression Profiles
    [CANCER RESEARCH 62, 3939–3944, July 15, 2002] Advances in Brief Comparison of Gene Expression Profiles between Hepatitis B Virus- and Hepatitis C Virus-infected Hepatocellular Carcinoma by Oligonucleotide Microarray Data on the Basis of a Supervised Learning Method1 Norio Iizuka, Masaaki Oka,2 Hisafumi Yamada-Okabe, Naohide Mori, Takao Tamesa, Toshimasa Okada, Norikazu Takemoto, Akira Tangoku, Kenji Hamada, Hironobu Nakayama, Takanobu Miyamoto, Shunji Uchimura, and Yoshihiko Hamamoto Departments of Surgery II [N. I., M. O., N. M., T. T., T. O., N. T., A. T.] and Bioregulatory Function [N. I.], Yamaguchi University School of Medicine, Yamaguchi 755-8505; Department of Computer Science and Systems Engineering, Faculty of Engineering, Yamaguchi University, Yamaguchi 755-8611 [T. M., S. U., Y. H.]; and Department of Oncology, Nippon Roche Research Center, Kanagawa 247-8530 [H. Y-O., K. H., H. N.], Japan Abstract nisms responsible for the pathogenesis of HCC differ between HBV and HCV infections. Several studies compared gene expression be- Gene expression profiles of hepatocellular carcinomas (HCCs) associ- tween nontumorous liver and HCC and revealed gene expression ated with hepatitis B virus (HBV) and hepatitis C virus (HCV) were patterns that are rather specific to HCC (10–14). However, there is analyzed and compared. Oligonucleotide microarrays containing >6000 genes and subsequent gene selection by a supervised learning method only one study that compared gene expression patterns between HCC yielded 83 genes for which expression differed between the two types of with HBV infection (B-type HCC) and HCC with HCV infection HCCs. Expression levels of 31 of these 83 genes were increased in HBV- (C-type HCC; 14), and only a limited number of specimens were associated HCCs, and expression levels of the remaining 52 genes were analyzed.
    [Show full text]
  • Discovery of Screening Biomarkers for Major Depressive Disorder in Remission by Proteomic Approach
    Article Discovery of Screening Biomarkers for Major Depressive Disorder in Remission by Proteomic Approach Hyebin Choi 1, Sora Mun 1, Eun-Jeong Joo 2,3, Kyu Young Lee 2,4, Hee-Gyoo Kang 1,5,* and Jiyeong Lee 6,* 1 Department of Senior Healthcare, Graduate School, Eulji University, Seongnam 13135, Korea; [email protected] (H.C.); [email protected] (S.M.) 2 Department of Neuropsychiatry, School of Medicine, Eulji University, Daejeon 34824, Korea; [email protected] (E.-J.J.); [email protected] (K.Y.L.) 3 Department of Psychiatry, Uijeongbu Eulji Medical Center, Eulji University, Gyeonggi 11759, Korea 4 Department of Psychiatry, Eulji General Hospital, Seoul 01830, Korea 5 Department of Biomedical Laboratory Science, College of Health Science, Eulji University, Seongnam 13135, Korea 6 Department of Biomedical Laboratory Science, College of Health Science, Eulji University, Uijeongbu 11759, Korea * Correspondence: [email protected] (H.-G.K.); [email protected] (J.L.); Tel.: +82-31-740-7315 (H.-G.K.); +82-42-259-1752 (J.L.) Abstract: Major depressive disorder (MDD) is a common disorder involving depressive mood and decreased motivation. Due to its high heterogeneity, novel biomarkers are required to diagnose MDD. In this study, a proteomic method was used to identify a new MDD biomarker. Using sequential window acquisition of all theoretical mass spectra acquisitions and multiple reaction monitoring analysis via mass spectrometry, relative and absolute quantification of proteins in the sera was per- formed. The results of the relative quantitation by sequential window acquisition for all theoretical mass spectra data showed that seven proteins were significantly differently expressed between MDD Citation: Choi, H.; Mun, S.; Joo, E.-J.; Lee, K.Y.; Kang, H.-G.; Lee, J.
    [Show full text]
  • The Structure, Function and Evolution of the Extracellular Matrix: a Systems-Level Analysis
    The Structure, Function and Evolution of the Extracellular Matrix: A Systems-Level Analysis by Graham L. Cromar A thesis submitted in conformity with the requirements for the degree of Doctor of Philosophy Department of Molecular Genetics University of Toronto © Copyright by Graham L. Cromar 2014 ii The Structure, Function and Evolution of the Extracellular Matrix: A Systems-Level Analysis Graham L. Cromar Doctor of Philosophy Department of Molecular Genetics University of Toronto 2014 Abstract The extracellular matrix (ECM) is a three-dimensional meshwork of proteins, proteoglycans and polysaccharides imparting structure and mechanical stability to tissues. ECM dysfunction has been implicated in a number of debilitating conditions including cancer, atherosclerosis, asthma, fibrosis and arthritis. Identifying the components that comprise the ECM and understanding how they are organised within the matrix is key to uncovering its role in health and disease. This study defines a rigorous protocol for the rapid categorization of proteins comprising a biological system. Beginning with over 2000 candidate extracellular proteins, 357 core ECM genes and 524 functionally related (non-ECM) genes are identified. A network of high quality protein-protein interactions constructed from these core genes reveals the ECM is organised into biologically relevant functional modules whose components exhibit a mosaic of expression and conservation patterns. This suggests module innovations were widespread and evolved in parallel to convey tissue specific functionality on otherwise broadly expressed modules. Phylogenetic profiles of ECM proteins highlight components restricted and/or expanded in metazoans, vertebrates and mammals, indicating taxon-specific tissue innovations. Modules enriched for medical subject headings illustrate the potential for systems based analyses to predict new functional and disease associations on the basis of network topology.
    [Show full text]
  • Evolution of Gene Regulation in Ruminants Differs Between Evolutionary Breakpoint Regions and Homologous Synteny Blocks
    Downloaded from genome.cshlp.org on September 27, 2021 - Published by Cold Spring Harbor Laboratory Press Research Evolution of gene regulation in ruminants differs between evolutionary breakpoint regions and homologous synteny blocks Marta Farré,1,18 Jaebum Kim,2,18 Anastasia A. Proskuryakova,3,4 Yang Zhang,5 Anastasia I. Kulemzina,3 Qiye Li,6 Yang Zhou,6 Yingqi Xiong,6 Jennifer L. Johnson,7 Polina L. Perelman,3,4 Warren E. Johnson,8,9 Wesley C. Warren,10 Anna V. Kukekova,7 Guojie Zhang,6,11,12 Stephen J. O’Brien,13,14 Oliver A. Ryder,15 Alexander S. Graphodatsky,3,4 Jian Ma,5 Harris A. Lewin,16 and Denis M. Larkin1,17 1Royal Veterinary College, University of London, London NW1 0TU, United Kingdom; 2Department of Biomedical Science and Engineering, Konkuk University, Seoul 05029, Korea; 3Institute of Molecular and Cellular Biology, SB RAS, Novosibirsk 630090, Russia; 4Synthetic Biology Unit, Novosibirsk State University, Novosibirsk 630090, Russia; 5Computational Biology Department, School of Computer Science, Carnegie Mellon University, Pittsburgh, Pennsylvania 15213, USA; 6China National GeneBank, BGI- Shenzhen, Shenzhen 518083, China; 7Department of Animal Sciences, College of Agricultural, Consumer and Environmental Sciences, University of Illinois at Urbana-Champaign, Urbana, Illinois 61801, USA; 8Smithsonian Conservation Biology Institute, National Zoological Park, Front Royal, Virginia 22630, USA; 9Walter Reed Biosystematics Unit, Museum Support Center, Smithsonian Institution, Suitland, Maryland 20746, USA; 10Bond Life Sciences Center, University of Missouri, Columbia, Missouri 63201, USA; 11State Key Laboratory of Genetic Resources and Evolution, Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming 650223, China; 12Centre for Social Evolution, Department of Biology, University of Copenhagen, DK-2100 Copenhagen, Denmark; 13Theodosius Dobzhansky Center for Genome Bioinformatics, St.
    [Show full text]
  • (SAA) Gene Cluster: Isoform Specific Responses to Bacterial Infection
    Organization and Biology of the Porcine Serum Amyloid A (SAA) Gene Cluster: Isoform Specific Responses to Bacterial Infection Helle G. Olsen1, Kerstin Skovgaard2, Ole L. Nielsen1,Pa´ll S. Leifsson1, Henrik E. Jensen1, Tine Iburg1¤, Peter M. H. Heegaard2* 1 Department of Veterinary Disease Biology, Faculty of Health and Medical Sciences, University of Copenhagen, Frederiksberg, Denmark, 2 Innate Immunology Group, National Veterinary Institute, Technical University of Denmark, Frederiksberg, Denmark Abstract Serum amyloid A (SAA) is a prominent acute phase protein. Although its biological functions are debated, the wide species distribution of highly homologous SAA proteins and their uniform behavior in response to injury or inflammation in itself suggests a significant role for this protein. The pig is increasingly being used as a model for the study of inflammatory reactions, yet only little is known about how specific SAA genes are regulated in the pig during acute phase responses and other responses induced by pro-inflammatory host mediators. We designed SAA gene specific primers and quantified the gene expression of porcine SAA1, SAA2, SAA3, and SAA4 by reverse transcriptase quantitative polymerase chain reaction (RT-qPCR) in liver, spleen, and lung tissue from pigs experimentally infected with the Gram-negative swine specific bacterium Actinobacillus pleuropneumoniae, as well as from pigs experimentally infected with the Gram-positive bacterium Staphylococcus aureus. Our results show that: 1) SAA1 may be a pseudogene in pigs; 2) we were able to detect two previously uncharacterized SAA transcripts, namely SAA2 and SAA4, of which the SAA2 transcript is primarily induced in the liver during acute infection and presumably contributes to circulating SAA in pigs; 3) Porcine SAA3 transcription is induced both hepatically and extrahepatically during acute infection, and may be correlated to local organ affection; 4) Hepatic transcription of SAA4 is markedly induced in pigs infected with A.
    [Show full text]